Amgen's Oncology Strategy: Building A Pipeline Of Novel Paradigm-Changing Drugs
Executive Summary
Amgen oncology development VP Greg Friberg talked to Scrip about the company's rapidly growing oncology portfolio. "This is our renaissance," he said.